APA (7th ed.) Citation

EY, C., CT, A., EL, Y., A, A., Z, A., O, B., . . . K, T. (2026). Efficacy and Safety of Rituximab Therapy to Sustain Remission in Young Children With Childhood Nephrotic Syndrome. Kidney international reports, 11(6), 106526. https://doi.org/10.1016/j.ekir.2026.106526

Chicago Style (17th ed.) Citation

EY, Chan, et al. "Efficacy and Safety of Rituximab Therapy to Sustain Remission in Young Children With Childhood Nephrotic Syndrome." Kidney International Reports 11, no. 6 (2026): 106526. https://doi.org/10.1016/j.ekir.2026.106526.

MLA (9th ed.) Citation

EY, Chan, et al. "Efficacy and Safety of Rituximab Therapy to Sustain Remission in Young Children With Childhood Nephrotic Syndrome." Kidney International Reports, vol. 11, no. 6, 2026, p. 106526, https://doi.org/10.1016/j.ekir.2026.106526.